(Q38783833)

English

CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies

scientific article published on 23 March 2016

In more languages
default for all languages
No label defined

No description defined

Statements

CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit